Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

ClinicalTrials.gov ID: NCT02624947

Public ClinicalTrials.gov record NCT02624947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Their Infants

Study identification

NCT ID
NCT02624947
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novavax
Industry
Enrollment
4,636 participants

Conditions and interventions

Interventions

  • RSV F vaccine with adjuvant Biological
  • Formulation buffer Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Dec 27, 2018
Completion
Jul 11, 2019
Last update posted
May 5, 2025

2015 – 2019

United States locations

U.S. sites
49
U.S. states
24
U.S. cities
46
Facility City State ZIP Site status
Research Site US115 Birmingham Alabama 35233
Research Site US035 Cullman Alabama 35058
Research Site US130 Fort Defiance Arizona 86504
Research Site US123 Phoenix Arizona 85004
Research Site US103 Tucson Arizona 85712
Research Site US129 Whiteriver Arizona 85941
Research Site US092 Colton California 92324
Research Site US114 Huntington Park California 90255
Research Site US127 Los Angeles California 90057
Research Site US091 Madera California 93637
Research Site US093 Riverside California 94201
Research Site US134 Aurora Colorado 80045
Research Site US036 Denver Colorado 80204
Research Site US040 Washington D.C. District of Columbia 20010
Research Site US037 Blackfoot Idaho 83221
Research Site US119 Idaho Falls Idaho 83404
Research Site US032 Nampa Idaho 83687
Research Site US095 Chicago Illinois 60611
Research Site US090 West Des Moines Iowa 50266
Research Site US038 Augusta Kansas 67010
Research Site US031 Hutchinson Kansas 67502
Research Site US096 Louisville Kentucky 40202
Research Site US126 Alexandria Louisiana 71301
Research Site US039 Metairie Louisiana 70006
Research Site US101 Detroit Michigan 48235
Research Site US098 Biloxi Mississippi 39531
Research Site US102 Lincoln Nebraska 68516
Research Site US025 Norfolk Nebraska 68701
Research Site US088 Neptune City New Jersey 07753
Research Site US131 Gallup New Mexico 87301
Research Site US087 Johnson City New York 13790
Research Site US086 Syracuse New York 13210
Research Site US020 Durham North Carolina 27710
Research Site US097 Fort Bragg North Carolina 28310
Research Site US089 Englewood Ohio 45322
Research Site US021 Pittsburgh Pennsylvania 15213
Research Site US116 Beaumont Texas 77702
Research Site US083 Fort Worth Texas 77555
Research Site US043 Galveston Texas 77555
Research Site US019 Houston Texas 77030
Research Site US128 Houston Texas 77036
Research Site US125 Lampasas Texas 76550
Research Site US094 Longview Texas 75605
Research Site US042 San Antonio Texas 78229
Research Site US121 Salt Lake City Utah 84107
Research Site US008 Salt Lake City Utah 84124
Research Site US099 Salt Lake City Utah 84132
Research Site US100 Richmond Virginia 23220
Research Site US041 Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02624947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02624947 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →